Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of February 28, 2026, Apogee Therapeutics, Inc. (APGE) has a Wall Street consensus price target of $108.86, based on estimates from 7 covering analysts. With the stock currently trading at $70.00, this represents a potential upside of +55.5%. The company has a market capitalization of $4.15B.
Analyst price targets range from a low of $83.00 to a high of $137.00, representing a 50% spread in expectations. The median target of $103.00 differs from the mean, suggesting potential outlier estimates.
The current analyst consensus rating is Buy, with 6 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, APGE trades at a trailing P/E of -21.2x. Analysts expect EPS to grow -13.5% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how APGE stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonThe consensus Wall Street price target for APGE is $108.86, representing 55.5% upside from the current price of $70. With 7 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
APGE has a consensus rating of "Buy" based on 7 Wall Street analysts. The rating breakdown is predominantly bullish, with 6 Buy/Strong Buy ratings. The consensus 12-month price target of $108.86 implies 55.5% upside from current levels.
APGE's current price is $70 with a consensus target of $108.86 (55.5% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $137 for APGE, while the most conservative target is $83. The consensus of $108.86 represents the median expectation. These targets typically reflect 12-month expectations.
APGE is moderately covered, with 7 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 6 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month APGE stock forecast based on 7 Wall Street analysts shows a consensus price target of $108.86, with estimates ranging from $83 (bear case) to $137 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on APGE, with a "Buy" consensus rating and $108.86 price target (55.5% upside). 6 of 7 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
APGE analyst price targets range from $83 to $137, a 50% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $108.86 consensus represents the middle ground.